These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30078083)

  • 1. Gadoxetic acid enhanced magnetic resonance imaging for prediction of the postoperative prognosis of intrahepatic mass-forming cholangiocarcinoma.
    Kim S; An C; Han K; Kim MJ
    Abdom Radiol (NY); 2019 Jan; 44(1):110-121. PubMed ID: 30078083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.
    Koh J; Chung YE; Nahm JH; Kim HY; Kim KS; Park YN; Kim MJ; Choi JY
    Eur Radiol; 2016 Feb; 26(2):407-16. PubMed ID: 26002136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.
    Haradome H; Unno T; Morisaka H; Toda Y; Kwee TC; Kondo H; Sano K; Ichikawa T; Kondo F; Sugitani M; Takayama T
    Eur Radiol; 2017 Nov; 27(11):4461-4471. PubMed ID: 28439650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers.
    Zhao L; Ma X; Liang M; Li D; Ma P; Wang S; Wu Z; Zhao X
    Cancer Imaging; 2019 Jul; 19(1):49. PubMed ID: 31307551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
    Min JH; Kim YK; Choi SY; Kang TW; Lee SJ; Kim JM; Ahn S; Cho H
    Radiology; 2019 Mar; 290(3):691-699. PubMed ID: 30620253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification for overall survival and recurrence-free survival after R0 resection for solitary intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
    Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
    Eur J Radiol; 2023 Dec; 169():111190. PubMed ID: 37979460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
    Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC
    Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
    Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
    J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC).
    Jin KP; Sheng RF; Yang C; Zeng MS
    Abdom Radiol (NY); 2022 Feb; 47(2):640-650. PubMed ID: 34820689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
    Sheng R; Zhang Y; Wang H; Zhang W; Jin K; Sun W; Dai Y; Zhou J; Zeng M
    Eur Radiol; 2024 Jan; 34(1):548-559. PubMed ID: 37552257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
    Shen K; Mo W; Wang X; Shi D; Qian W; Sun J; Yu R
    Eur Radiol; 2023 Dec; 33(12):8986-8998. PubMed ID: 37392232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation.
    Jeong HT; Kim MJ; Chung YE; Choi JY; Park YN; Kim KW
    AJR Am J Roentgenol; 2013 Oct; 201(4):W603-11. PubMed ID: 24059399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI.
    Chang AI; Kim YK; Min JH; Lee J; Kim H; Lee SJ
    Abdom Radiol (NY); 2019 Apr; 44(4):1395-1406. PubMed ID: 30515535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cloud sign of mass-forming intrahepatic cholangiocarcinoma.
    Teo T; Chawla A
    Abdom Radiol (NY); 2020 Jan; 45(1):237-238. PubMed ID: 31712866
    [No Abstract]   [Full Text] [Related]  

  • 16. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
    Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
    Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
    Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
    Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS
    Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram based on MRI for preoperative prediction of Ki-67 expression in patients with intrahepatic mass cholangiocarcinoma.
    Chen X; Zhu J; Zou Z; Du M; Xie J; Ye Y; Zhang L; Li Y
    Abdom Radiol (NY); 2023 Feb; 48(2):567-578. PubMed ID: 36401626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.
    Joo I; Lee JM; Lee SM; Lee JS; Park JY; Han JK
    J Magn Reson Imaging; 2016 Nov; 44(5):1330-1338. PubMed ID: 27087012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.